Amyloidosis and Alzheimer's disease diagnostic assay and reagent

Details Amyloidosis and Alzheimer's disease diagnostic assay and reagent Amyloidosis and Alzheimer's disease diagnostic assay and reagent

1988-04-06

1990-06-12

Maples, John S.

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

534670, 534671, 534673, A61K 4902, C09B 31065

Patent

active

049331566

ABSTRACT:
The presence and location of amyloid deposits in an organ or body area of a patient is effected by intravenous administration of novel radioactive iodine-labeled amyloid binding compounds and preferably .sup.123 I-labeled compounds to the patient and sensing radiation emitted from the organ or body area. Novel non-radioactive iodine substituted amyloid binding compounds and amyloid binding compounds which are readily iodinated are further aspects of the invention.

REFERENCES:
patent: 1626167 (1927-04-01), Straub
patent: 4006131 (1977-02-01), Uehlinger

Affiliated with

Also associated with

Rating

Amyloidosis and Alzheimer's disease diagnostic assay and reagent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amyloidosis and Alzheimer's disease diagnostic assay and reagent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amyloidosis and Alzheimer's disease diagnostic assay and reagent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-616092